VEO Ophthalmics and VitaPixel are launching an exclusive commercialization partnership for Vita’s stereoscopic digital visualization system.
Before we talk details, let's get a look at these companies.
First up: VEO. Operating out of Ohio, the medical device developer and distributor specializes in ophthalmic surgical technologies for the treatment of lens disorders.
Among these products:
- CUSTOMFLEX ARTIFICIALIRIS, an FDA-approved device for use as an iris prosthesis to treat iris defects in both pediatric and adult patients
- VisionOne, an FDA-cleared portable perimeter device for performing visual field tests via a virtual reality (VR) headset with cloud-based analysis
- Note: This was the subject of a 2025 strategic partnership with VisionOne VR.
And VitaPixel?
Based in Pennsylvania, the medical equipment manufacturer was co-founded by a retina surgeon specializing in 3D screen-based visualization.
- See its full story, executive team, and medical device advisors.
- To note: VEO’s President and CEO Ron Gilliland is among the latter.
As for its manufacturing focus—that would be the focus of our coverage: VitaPixel SVS.
Check out more on the impetus for this technology.
Before we talk about that system, let’s get some partnership details.
There’s really not much to it (or, rather, that has been publicly disclosed).
The exclusive commercialization agreement involves VEO heading up VitaPixel’s global commercialization.
What this involves: VEO will handle all aspects of the system’s sales and marketing as a commercialization pattern, while VitaPixel will focus on the research and development (R&D) and manufacturing.
No other details—including monetary—were shared.
Gotcha. Next up: VitaPixel SVS.
VitaPixel SVS is a stereoscopic digital visualization and imaging system designed to integrate with existing slit-lamp systems.
How: by replacing a slit lamp’s binocular view with a stereoscopic view via organic light-emitting diode (OLED) micro-display glasses—essentially removing the need for a surgeon to position their head at the slit-lamp oculars.
Tell me more.
The system ensures the left and right channels are separate from the eyepieces to the glasses.
And behind each eyepiece: A high-sensitivity image sensor provides a high dynamic range that holds “the brightest beam and the darkest shadow at the same time.”
And how does it fit into an existing slit lamp system, exactly?
Basically: The SVS’s cameras peer through an (existing) slit lamp’s eye pieces to capture the view through the optics and magnifications a surgeon already uses.
The cameras can be easily flipped up to allow a surgeon back at the oculars.
- The recommendation: “Use the glasses for the exams that suit them and the direct optics for the ones that don’t.”
See here for visuals comparing the SVS camera view to a conventional camera view.
So what advantages come with this?
Four key capabilities are targeted. The first two:
Ergonomics: The system’s display glasses bring the exam to a surgeon, enabling a more natural and upright position at the slit lamp.
- See here for how this works.
Digital documentation (at the slit lamp): 3D visualization plus image and video are captured from the live view via the joystick button or tapping a 2D touchscreen attached directly to the slit lamp.
- Surgeons can review, annotate, and export these visuals.
- DICOM compliance, PACS integration, local session auto-save, and USB export are also included.
And the other two?
Patient comfort: The system is designed around flexible positioning and lowered required illumination.
- What this means: Since the surgeon doesn’t need to be at the oculars, the exam can be built around the patient (and not the slit lamp). See how it works.
Teaching and training: Students and residents can follow a surgeon’s live slit lamp view via two options: a second pair of display glasses or on a 3D display for the room.
- The intent: to support case-based learning, skills assessment, mentoring, and collaborative discussion. More details here.
Impressive! So is this cleared for use in the U.S.?
The system is reported to be an FDA-listed, Class II medical device.
Only question left to ask: When will it be available?
VEO is introducing VitaPixel SVS during the American Academy of Ophthalmology (AAO) annual meeting in New Orleans, Louisiana, this weekend.
For surgeons interested in learning more (and receiving a demo!), stop by booth #2300.
And if I’m not attending AAO?
Click here to inquire about booking a demo.
Looking ahead: Units are expected to be available by the end of Q4 2026.